Literature DB >> 8396685

Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.

C L Chen1, R H Sadler, D M Walling, I J Su, H C Hsieh, N Raab-Traub.   

Abstract

Epstein-Barr virus (EBV) DNA has been detected in peripheral T-cell lymphomas. In this study, analysis of the EBV termini indicated that the infection was clonal and nonpermissive. Analysis of viral expression detected the processed, spliced mRNAs representing EBNA1, LMP1, LMP2, and BamHI A transcripts in all EBV-positive peripheral T-cell lymphomas. The LMP1 protein was detected by immunofluorescence in a single specimen. In contrast, neither the EBNA2 protein nor the spliced EBNA2 mRNA were detected. These data indicate that EBV-infected T-cell lymphomas are clonal expansions of a single EBV-infected cell with a pattern of gene expression which is distinct from that detected in Burkitt's lymphomas or posttransplant lymphomas but similar to viral expression in nasopharyngeal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396685      PMCID: PMC238058     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma.

Authors:  Y Harabuchi; N Yamanaka; A Kataura; S Imai; T Kinoshita; F Mizuno; T Osato
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

2.  Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype.

Authors:  I J Su; K H Lin; C J Chen; H F Tien; H C Hsieh; D T Lin; J Y Chen
Journal:  Cancer       Date:  1990-12-15       Impact factor: 6.860

3.  Two related Epstein-Barr virus membrane proteins are encoded by separate genes.

Authors:  J Sample; D Liebowitz; E Kieff
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease.

Authors:  L M Weiss; L A Movahed; R A Warnke; J Sklar
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

5.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

6.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China.

Authors:  M L Lung; R S Chang; M L Huang; H Y Guo; D Choy; J Sham; S Y Tsao; P Cheng; M H Ng
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

8.  Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.

Authors:  K Gilligan; H Sato; P Rajadurai; P Busson; L Young; A Rickinson; T Tursz; N Raab-Traub
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

9.  Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis.

Authors:  I J Su; H C Hsieh; K H Lin; W C Uen; C L Kao; C J Chen; A L Cheng; M E Kadin; J Y Chen
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

10.  EBV gene expression in an NPC-related tumour.

Authors:  M M Hitt; M J Allday; T Hara; L Karran; M D Jones; P Busson; T Tursz; I Ernberg; B E Griffin
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  26 in total

1.  Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.

Authors:  Jingwu Xu; Ali Ahmad; José Menezes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.

Authors:  Huai-Chia Chuang; Jong-Ding Lay; Shuang-En Chuang; Wen-Chuan Hsieh; Yao Chang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

3.  Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.

Authors:  M Guan; R D Zhang; B Wu; E E Henderson
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

4.  The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.

Authors:  Q Tao; K D Robertson; A Manns; A Hildesheim; R F Ambinder
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

5.  A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.

Authors:  C Nonkwelo; I K Ruf; J Sample
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.

Authors:  A A Brink; D F Dukers; A J van den Brule; J J Oudejans; J M Middeldorp; C J Meijer; M Jiwa
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

8.  IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.

Authors:  Loránd L Kis; Daniel Salamon; Emma K Persson; Noémi Nagy; Ferenc A Scheeren; Hergen Spits; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo.

Authors:  Amber N Shatzer; Michael Graham Espey; Mayra Chavez; Hongbin Tu; Mark Levine; Jeffrey I Cohen
Journal:  Leuk Lymphoma       Date:  2012-11-15

10.  Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.

Authors:  K A Taylor; S Wetzel; D S Lyles; B A Pollok
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.